OCT wins Healthcare & Life Sciences Awards 2017

BOSTON - Nov. 22, 2017 - PRLog -- "We invited over 100,000 corporate and medical professionals, the public and our subscribers to participate in the awards process. In addition, Corporate LiveWire's extensive research team nominated individuals who have excelled within the healthcare and medical sector," comments James Drakeford, Editor-in-Chief at Corporate LiveWire.

To apply for the award, OCT provided information about its business and shared some notable achievements over the last 12 months. Here are some of them:

·      OCT is among TOP-3 CROs (https://www.oct-clinicaltrials.com/news/2414) with the largest number of international multicenter clinical trials approved by the Ministry of Health in the second quarter of 2016

·      OCT is #1 CRO in 2016 (https://www.oct-clinicaltrials.com/news/2562) with the number of obtained approvals of clinical and bioequivalence trials in 2016

·      OCT is among TOP 25 Life Science Innovators 2017

·      OCT tops the list of the leading CROs in 3Q 2017 (https://www.centerwatch.com/news-online/2017/11/02/oct-to...)

It is also worth noting that OCT expanded the staff by one-third in a year, as the number of turn-key project increased.

"Our company is passionate about creating a reliable community of clinical trial professionals with high standards of work in Russia. For this purpose, OCT holds its annual conference 'Clinical Trials In And Outside Russia' with more than 300 attendees for all industry experts. I believe, such events really drive the industry,' says Dmitry Sharov, OCT President.